Cipla Ltd. To Buy Meditab For $28M

August 25, 2010 |

1 min read

in-Pharma Technologist -- Indian pharmaceutical firm Cipla is to buy Meditab Specialties to boost active pharmaceutical ingredient (API) and intermediate production capacity.

Mergers & acquisitions Asia

MORE ON THIS TOPIC

Rheumatoid arthritis (RA) commonly causes inflammation in the hands, leading to pain, swelling, and stiffness in the joints, particularly the small joints of the fingers and wrists. This inflammation results from the immune system attacking the body's own joint tissues, causing the synovium (lining of the joint) to become inflamed and release chemicals that damage nearby tissues.

Mergers & acquisitions

Sobi Makes $1.5B Gout Play With Arthrosi Acquisition

December 15, 2025

·

2 min read

·

Tristan Manalac

Podcast

Weight Loss Waves, Pazdur’s Exit and FDA Instability, New Neuro Breakthroughs

December 10, 2025

·

1 min read

·

Heather McKenzie

Hand with the ace of Spades playing card. Vintage color engraving stylized drawing. Vector illustration

Mergers & acquisitions

Pfizer Is Not a Done Dealmaker After Metsera Buy, With $6B More To Spend

December 10, 2025

·

1 min read

·

Annalee Armstrong

Hands holding red circle. Sensing energy between palms. Concept of human relation, togetherness, partnership, connection, contact or network. Design for banner, flyer, poster, cover or brochure.

Japan

Japanese Pharmas Looking Beyond Borders for M&A to US, EU

December 10, 2025

·

7 min read

·

Dan Samorodnitsky